164 related articles for article (PubMed ID: 28060749)
1. NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling.
Zhu Y; Zhang JJ; Peng YP; Liu X; Xie KL; Tang J; Jiang KR; Gao WT; Tian L; Zhang K; Xu ZK; Miao Y
Oncotarget; 2017 Feb; 8(6):10385-10399. PubMed ID: 28060749
[TBL] [Abstract][Full Text] [Related]
2. The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer.
Tang J; Zhu Y; Xie K; Zhang X; Zhi X; Wang W; Li Z; Zhang Q; Wang L; Wang J; Xu Z
J Exp Clin Cancer Res; 2016 Jun; 35(1):91. PubMed ID: 27287498
[TBL] [Abstract][Full Text] [Related]
3. Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling.
Zhu Y; Zhang JJ; Xie KL; Tang J; Liang WB; Zhu R; Zhu Y; Wang B; Tao JQ; Zhi XF; Li Z; Gao WT; Jiang KR; Miao Y; Xu ZK
J Transl Med; 2014 Nov; 12():309. PubMed ID: 25367394
[TBL] [Abstract][Full Text] [Related]
4. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells.
Senapati S; Gnanapragassam VS; Moniaux N; Momi N; Batra SK
Oncogene; 2012 Jul; 31(28):3346-56. PubMed ID: 22105367
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4.
Xie K; Zhi X; Tang J; Zhu Y; Zhang J; Li Z; Tao J; Xu Z
Oncol Rep; 2014 May; 31(5):2187-94. PubMed ID: 24676527
[TBL] [Abstract][Full Text] [Related]
6. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
7. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
8. Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades.
Kunigal S; Ponnusamy MP; Momi N; Batra SK; Chellappan SP
Mol Cancer; 2012 Apr; 11():24. PubMed ID: 22537161
[TBL] [Abstract][Full Text] [Related]
9. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
[TBL] [Abstract][Full Text] [Related]
10. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
[TBL] [Abstract][Full Text] [Related]
11. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.
Jahan R; Macha MA; Rachagani S; Das S; Smith LM; Kaur S; Batra SK
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2538-2549. PubMed ID: 29777904
[TBL] [Abstract][Full Text] [Related]
12. Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells.
Li Y; Wu C; Chen T; Zhang J; Liu G; Pu Y; Zhu J; Shen C; Zhang Y; Zeng N; Zhang X
Oncol Rep; 2016 Dec; 36(6):3449-3455. PubMed ID: 27748843
[TBL] [Abstract][Full Text] [Related]
13. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
[TBL] [Abstract][Full Text] [Related]
14. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.
Torres MP; Ponnusamy MP; Chakraborty S; Smith LM; Das S; Arafat HA; Batra SK
Mol Cancer Ther; 2010 May; 9(5):1419-31. PubMed ID: 20423995
[TBL] [Abstract][Full Text] [Related]
15. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells.
Lakshmanan I; Seshacharyulu P; Haridas D; Rachagani S; Gupta S; Joshi S; Guda C; Yan Y; Jain M; Ganti AK; Ponnusamy MP; Batra SK
Oncotarget; 2015 Aug; 6(25):21085-99. PubMed ID: 26035354
[TBL] [Abstract][Full Text] [Related]
16. The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways.
Jonckheere N; Skrypek N; Merlin J; Dessein AF; Dumont P; Leteurtre E; Harris A; Desseyn JL; Susini C; Frénois F; Van Seuningen I
PLoS One; 2012; 7(2):e32232. PubMed ID: 22393391
[TBL] [Abstract][Full Text] [Related]
17. Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.
Duraisamy S; Ramasamy S; Kharbanda S; Kufe D
Gene; 2006 May; 373():28-34. PubMed ID: 16500040
[TBL] [Abstract][Full Text] [Related]
18. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma.
Choudhury A; Moniaux N; Winpenny JP; Hollingsworth MA; Aubert JP; Batra SK
J Biochem; 2000 Aug; 128(2):233-43. PubMed ID: 10920259
[TBL] [Abstract][Full Text] [Related]
19. AMOP, a protein module alternatively spliced in cancer cells.
Ciccarelli FD; Doerks T; Bork P
Trends Biochem Sci; 2002 Mar; 27(3):113-5. PubMed ID: 11893501
[TBL] [Abstract][Full Text] [Related]
20. Alternate splicing at the 3'-end of the human pancreatic tumor-associated mucin MUC4 cDNA.
Choudhury A; Moniaux N; Ringel J; King J; Moore E; Aubert JP; Batra SK
Teratog Carcinog Mutagen; 2001; 21(1):83-96. PubMed ID: 11135323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
